Bio-Techne Corp TECH
Latest 10-Q
What changed in Bio-Techne Corp's latest quarterly report, compared with the one before.
Loading…
Insider trades
Open-market trades from Form 4. 10b5-1 marks a plan set in advance.Open-market buys and sales by officers, directors and 10% owners, from SEC Form 4. A plan set in advance is marked 10b5-1.
Loading…
13F holders
Funds that report this stock, checked against market prices.Fund managers with over $100 million in US-listed stocks file a 13F each quarter, up to 45 days after quarter end. Long positions only.
Loading…
Trades by members of Congress
Disclosed in dollar ranges, up to 45 days after the trade.Members of Congress, their spouses and dependent children report trades in dollar ranges, up to 45 days after the trade.
Loading…
Executive-branch trades
2 tradesTrades in Bio-Techne Corp reported by the President, Cabinet members and other senior executive-branch officials. Amounts are ranges.Form 278-T is the periodic transaction report that senior executive-branch officials file with the Office of Government Ethics. They must report each trade over $1,000 within 30 days of being notified of it, and no later than 45 days after the trade. Amounts are ranges, not exact figures.
| The form has no ticker column. The asset is shown as the filer wrote it. We add a ticker link only when we could match the asset to a listed company. | The form asks for a range, such as $1,001 - $15,000, not an exact amount. A line can be left blank when the filer's note says the amount was not more than $1,000. | Report | ||||
|---|---|---|---|---|---|---|
| Donald J Trump President of the United States | BIO TECHNE CORP COM read from scan | Sale | Apr 27, 2026 | $15,001 - $50,000 | Jun 25, 2026 | White House report ↗ |
| Donald J Trump President of the United States | BIO TECHNE CORP COM UNSOLICITED read from scan | Purchase | Mar 23, 2026 | $15,001 - $50,000 | May 8, 2026 | White House report ↗ |
Lobbying
What Bio-Techne Corp and its lobbying firms report each quarter.A company that lobbies with its own staff reports its expenses; a lobbying firm it hires reports the income it received. We count both.
Loading…
Capitol Hires at Bio-Techne Corp
2 hiresLobbyists for Bio-Techne Corp who say they once worked in Congress or the executive branch.
| The covered position the lobbyist says they held: an office of a member of Congress, a committee or an executive-branch body, as written in the filing. The member's name is a link only when exactly one member of Congress fits the name, chamber, first name and years given; otherwise it stays as written. | The lobbying report (LDA form LD-2) that names this lobbyist and office, with a link to it. Report period is the quarter the report covers; Posted is the day it was filed or amended, which can be much later. The same lobbyist is named again on each quarterly report for the same client, so a row is shown once, from the newest report, with the number of filings that name them. | |||
|---|---|---|---|---|
| Kara-Marie Urban | Senate Finance Cmte Committee · 2018 | Intern | Squire Patton Boggs | Report period 2026 Q1 ↗ Posted Apr 15, 2026 · in 2 filings |
| Kara-Marie Urban | House Ways and Means Cmte Committee · 2019 | Intern | Squire Patton Boggs | Report period 2026 Q1 ↗ Posted Apr 15, 2026 · in 2 filings |
Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered.
Institutional ownership over time
How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.
Loading…
More filings and data
Each opens the table.
About the company
The basics from the company’s SEC registration.
Loading…
Adjusted for stock splits; not for dividends. Where prices come from.
Live chart
Intraday and historical prices from TradingView. Quotes may be delayed.
Information, not investment advice. Company matching is automatic; check the source before relying on one row.